中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
4期
913-915
,共3页
牛宁奎%王骞%施建党%王自立%耿广起%金卫东
牛寧奎%王鶱%施建黨%王自立%耿廣起%金衛東
우저규%왕건%시건당%왕자립%경엄기%금위동
脊柱结核%外周血%基因表达谱
脊柱結覈%外週血%基因錶達譜
척주결핵%외주혈%기인표체보
Spinal tuberculosis%Peripheral blood%Gene expression profiles
目的 探讨超短程化疗治疗脊柱结核临床疗效与外周血mRNA基因表达谱的关系.方法 实验组为27例脊柱结核患者,分为3组:A组(未治疗时段组)8例、B组(治疗结束时段组)9例、C组(1年随访时段组)10例.对照组为5例非结核患者.利用基因芯片筛选外周血差异表达基因,并对外周血炎性细胞因子及核转录因子(NF)-κB检测.结果 临床结果显示A组结核病灶活动;B、C两组结核病灶治愈.基因表达谱提示实验组、对照组有1 895个差异有统计学意义的基因;A、B组之间显著差异表达基因942个,上调936个,下调6个,这些基因主要参与炎症及宿主的免疫调节机制;B、C组之间表现为30条非特异性差异基因.A组较B、C两组肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-y)、白细胞介素-12(IL-12)、白细胞介素-8(IL-8)表达水平明显升高,这与NF-κB的表达水平相一致.结论 超短程化疗治疗脊柱结核的临床疗效与外周血mRNA基因表达水平相一致;外周血mRNA表达谱芯片可用于评估超短程化疗疗效.
目的 探討超短程化療治療脊柱結覈臨床療效與外週血mRNA基因錶達譜的關繫.方法 實驗組為27例脊柱結覈患者,分為3組:A組(未治療時段組)8例、B組(治療結束時段組)9例、C組(1年隨訪時段組)10例.對照組為5例非結覈患者.利用基因芯片篩選外週血差異錶達基因,併對外週血炎性細胞因子及覈轉錄因子(NF)-κB檢測.結果 臨床結果顯示A組結覈病竈活動;B、C兩組結覈病竈治愈.基因錶達譜提示實驗組、對照組有1 895箇差異有統計學意義的基因;A、B組之間顯著差異錶達基因942箇,上調936箇,下調6箇,這些基因主要參與炎癥及宿主的免疫調節機製;B、C組之間錶現為30條非特異性差異基因.A組較B、C兩組腫瘤壞死因子-α(TNF-α)、榦擾素-γ(IFN-y)、白細胞介素-12(IL-12)、白細胞介素-8(IL-8)錶達水平明顯升高,這與NF-κB的錶達水平相一緻.結論 超短程化療治療脊柱結覈的臨床療效與外週血mRNA基因錶達水平相一緻;外週血mRNA錶達譜芯片可用于評估超短程化療療效.
목적 탐토초단정화료치료척주결핵림상료효여외주혈mRNA기인표체보적관계.방법 실험조위27례척주결핵환자,분위3조:A조(미치료시단조)8례、B조(치료결속시단조)9례、C조(1년수방시단조)10례.대조조위5례비결핵환자.이용기인심편사선외주혈차이표체기인,병대외주혈염성세포인자급핵전록인자(NF)-κB검측.결과 림상결과현시A조결핵병조활동;B、C량조결핵병조치유.기인표체보제시실험조、대조조유1 895개차이유통계학의의적기인;A、B조지간현저차이표체기인942개,상조936개,하조6개,저사기인주요삼여염증급숙주적면역조절궤제;B、C조지간표현위30조비특이성차이기인.A조교B、C량조종류배사인자-α(TNF-α)、간우소-γ(IFN-y)、백세포개소-12(IL-12)、백세포개소-8(IL-8)표체수평명현승고,저여NF-κB적표체수평상일치.결론 초단정화료치료척주결핵적림상료효여외주혈mRNA기인표체수평상일치;외주혈mRNA표체보심편가용우평고초단정화료료효.
Objective Evaluate the relationship between the clinical efficacy of spinal tuberculosis using ultra-short-course chemotherapy (UCCT) and peripheral blood messenger RNA (mRNA) gene expressions.Methods The study group was composed of peripheral blood samples from 27 spinal TB patients,and it was divided into three groups:group A (untreated group) 8 cases,group B (treatment-completed group) 9 cases,and group C (1-yr follow-up group) 10 cases.The control group was made up of the peripheral blood samples from 5 non TB patients.Gene chip was employed to detect the differentially expressed gene in the peripheral blood samples.Detect the peripheral inflammatory cytokines and nuclear transcription factor κB (NF-κB).Results Clinical result showed that the tuberculosis lesions in group A were active; while tuberculosis lesions in both group B and group C were all cured.The mRNA expression profiles in peripheral blood showed there were 1895 differentially expressed genes between study group and control group.However,there were 942 differentially expressed genes between group A and B,936 genes up-regulated and 6 genes down-regulated,and the functions of these differentially expressed genes were mainly related to the immune regulation of patients.No differential expressed genes were identified between group B and C,and they were non-specific differences 30 genes.Group A compared with group B and group C showed that tumor necrosis factor (TNF-α),interferon-gamma (IFN-γ),interleukin-12 (IL-12),and interleukin-8 (IL-8) expression levels were significantly increased,which were consistent with the level of expression of NF-κB.Conclusion The clinical efficacy of UCCT for spinal tuberculosis was consistent with peripheral blood gene expressions,protein expression of inflammatory cytokines,and the level of NF-κB; mRNA gene expression profiles can be used to assess the efficacy of UCCT.